AISHA ALYASSI et al. GLP-1 RECEPTOR AGONISTS AS A BREAKTHROUGH THERAPY FOR OBESITY AND METABOLIC SYNDROME: A SYSTEMATIC REVIEW OF EFFICACY AND LONG-TERM OUTCOMES. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 11, p. 1915–1925, 2024. DOI: 10.53555/6tdd8g65. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/9100. Acesso em: 11 sep. 2025.